Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Revenue by Segment

536 Followers

Revenue by Segment

Bio-Techne reported revenue by segment of $299.71M in Q1 FY2027, down 6.7% from Q4 FY2026 and up 4.6% year over year. The highest value was $321.19M in Q4 FY2026.

Breaks total sales into the company’s product or business-line categories so you can see which areas drive growth and which lag. Useful for assessing diversification, dependence on key products, and where management is allocating resources to expand or defend market share.

-$50.00M$0.00$50.00M$100.00M$150.00M$200.00M$250.00M$300.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Protein Sciences is the clear revenue anchor—steady, resilient and recovering after cyclical dips—while Diagnostics & Spatial Biology is the fastest-growing diversifier, delivering consistent quarter-to-quarter expansion that should underpin long-term margin improvement. Small 'Other' contributions and large swings in intersegment eliminations look like accounting/reclassification noise (and one apparent 2026‑Q1 Protein Sciences data anomaly); don’t mistake those blips for underlying operating momentum—watch core segment trends and underlying bookings for true signal.

TECH Revenue by Segment

PeriodOtherIntersegmentProtein SciencesDiagnostics and Spatial BiologyTotal
Q1 FY2027Sep 30, 2026$0.00-$143.00K$219.69M$80.16M$299.71M
Q4 FY2026Jun 30, 2026$0.00-$144.00K$231.19M$90.14M$321.19M
Q3 FY2026Mar 31, 2026$0.00-$325.00K$221.54M$85.59M$306.80M
Q2 FY2026Dec 31, 2025$0.00-$387.00K$215.08M$81.18M$295.88M
Q1 FY2026Sep 30, 2025$5.44M-$530.00K$202.19M$79.46M$286.56M
Q4 FY2025Jun 30, 2025$0.00$787.00K$226.47M$89.70M$316.96M
Q3 FY2025Mar 31, 2025$0.00-$737.00K$227.69M$89.23M$316.18M
Q2 FY2025Dec 31, 2024$1.85M-$504.00K$211.55M$84.14M$297.03M
Q1 FY2025Sep 30, 2024$2.30M-$572.00K$204.53M$83.19M$289.46M
Q4 FY2024Jun 30, 2024$2.06M-$628.00K$213.99M$90.68M$306.10M
Q3 FY2024Mar 31, 2024$2.09M-$765.00K$214.59M$87.51M$303.43M
Q2 FY2024Dec 31, 2023$0.00-$480.00K$197.67M$75.41M$272.60M
Q1 FY2024Sep 30, 2023$0.00-$517.00K$204.66M$72.80M$276.94M
Q4 FY2023Jun 30, 2023$0.00-$713.00K$223.01M$79.03M$301.32M
Q3 FY2023Mar 31, 2023$0.00-$426.00K$218.90M$75.67M$294.15M
Q2 FY2023Dec 31, 2022$0.00-$309.00K$203.89M$68.00M$271.58M
Q1 FY2023Sep 30, 2022$0.00-$198.00K$199.95M$69.90M$269.65M
Q4 FY2022Jun 30, 2022$0.00-$402.00K$216.98M$71.65M$288.23M
Q3 FY2022Mar 31, 2022$0.00-$479.00K$213.18M$77.68M$290.38M
Q2 FY2022Dec 31, 2021$0.00-$222.00K$204.97M$64.53M$269.28M
Q1 FY2022Sep 30, 2021$0.00-$452.00K$197.19M$60.98M$257.72M
Q4 FY2021Jun 30, 2021$0.00-$345.00K$192.32M$67.06M$259.03M
Q3 FY2021Mar 31, 2021$0.00-$164.00K$185.62M$58.09M$243.55M
Q2 FY2021Dec 31, 2020$0.00-$395.00K$172.18M$52.47M$224.25M
Q1 FY2021Sep 30, 2020$0.00-$372.00K$154.45M$50.13M$204.20M

Related KPIs